Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

View Vertex Pharmaceuticals Incorporated (VRTX) current and estimated P/E ratio data provided by Seeking Alpha.

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

BOSTON - Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX) is set to present pivotal Phase 3 data on suzetrigine, an investigational non-opioid pain signal... ByInvesting.com • Oct ...

Vertex Pharmaceuticals is adding a new cystic fibrosis ... Starting Jan. 2, the company’s stock symbol on the Nasdaq will be “ONC.” —Applied Therapeutics received a double dose of bad ...

Belo Sun Mining Corp. ("Belo Sun" or the "Company" is pleased to announce the appointment of Mr. Jack Lunnon as a director of the Company with immediate effect. Mr. Lunnon is a nominee of La Mancha ...

Formed in 2019, Sionna's most recent financing was a $182 million third round that closed last year, which followed a $111 ...

Vertex Pharmaceuticals (VRTX) closed at $428 in the latest trading session, marking a +0.03% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.61%.

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...